Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
3.200
+0.030 (0.95%)
At close: May 22, 2026, 4:00 PM EDT
3.200
0.00 (0.00%)
After-hours: May 22, 2026, 6:07 PM EDT
Cellectar Biosciences Employees
Cellectar Biosciences had 11 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,894,632
Market Cap
26.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | 0 | - |
| Dec 31, 2024 | 11 | -9 | -45.00% |
| Dec 31, 2023 | 20 | 5 | 33.33% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Dec 31, 2021 | 12 | 1 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 123 |
| Vistagen Therapeutics | 59 |
| Palatin Technologies | 29 |
| Jasper Therapeutics | 22 |
| Sensei Biotherapeutics | 15 |
| Skye Bioscience | 12 |
| Allarity Therapeutics | 8 |
| Dyadic International | 6 |
CLRB News
- 3 days ago - Cellectar Biosciences files to sell 51.21M shares of common stock for holders - TheFly
- 3 days ago - Cellectar Biosciences Registration statement: Registration filing - Filings
- 4 days ago - Cellectar Biosciences Proxy statement: Proxy filing - Filings
- 7 days ago - Cellectar Biosciences assumed with a Buy at Ladenburg - TheFly
- 8 days ago - Cellectar Biosciences Earnings Call Transcript: Q1 2026 - Transcripts
- 8 days ago - Cellectar Biosciences Quarterly report: Q1 2026 - Filings
- 8 days ago - Cellectar Biosciences Earnings release: Q1 2026 - Filings
- 8 days ago - Cellectar Biosciences reports Q1 EPS ($1.33), consensus ($1.88) - TheFly